COMP <GO>

CR vs TMO // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Crane Company (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: CR 12 — TMO 3

▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: TMO

LAST: $198.02 (-3.79%) • MKT CAP: $11.90B

options-implied-move

7.20%

LAST: $697.00 (-1.72%) • MKT CAP: $262.22B

options-implied-move

6.70%

15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CR VS. TMO) EMERALD CELL = QUANTITATIVE EDGE

INSTITUTIONAL METRIC	CR	TMO	SPREAD (A - B)	ADVANTAGE	DEDICATED URL
Gross Profit Margin	42.20%	41.00%	+1.20	CR	/gross-margins <GO>
Return on Invested Capital (ROIC)	12.40%	9.30%	+3.10	CR	/roic <GO>
EV/EBITDA & P/E Valuation	24.5x	30.4x	-5.90	CR	/valuation <GO>
Free Cash Flow Yield	2.64%	2.40%	+0.24	CR	/fcf-yield <GO>
Operating Margin	18.40%	17.40%	+1.00	CR	/operating-margins <GO>
Net Profit Margin	15.90%	15.10%	+0.80	CR	/net-margins <GO>
Revenue Growth (YoY)	8.20%	3.90%	+4.30	CR	/revenue-growth <GO>
Dividend Yield & FCF Payout Safety	0.44%	0.24%	+0.20	CR	/dividend-safety <GO>
Altman Z-Score & Debt/Equity	6.16	4.50	+1.66	CR	/balance-sheet <GO>
Piotroski F-Score Quality	9/9	8/9	+1.00	CR	/piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE	7.20%	6.70%	+0.50	TMO	/options-implied-move <GO>
RSI-14 & 200D SMA Momentum	47.4	59.1	-11.73	TMO	/rsi-technicals <GO>
10Y Yield & FRED Macro Beta	1.09	0.94	+0.15	CR	/macro-sensitivity <GO>
Forward P/E Multiple	30.1x	36.3x	-6.20	CR	/forward-pe <GO>
Enterprise Scale & Market Cap	$11.90B	$262.22B	-$250.32B	TMO	/market-cap <GO>

5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY

FISCAL YEAR	CR REV	TMO REV	CR GROSS %	TMO GROSS %	CR FCF	TMO FCF
FY 2025	$2.31B	$44.56B	42.2%	44.0%	$306.9M	$6.29B
FY 2024	$2.13B	$42.88B	40.7%	44.0%	$234.2M	$7.27B
FY 2023	$1.86B	$42.86B	44.0%	44.0%	$202.8M	$6.48B

FRED MACRO REGIME CORRELATION COMPARISON PEARSON r

CR // BETA 1.09

TMO // BETA 0.94